These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8095411)
1. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Hynes NE Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853 [TBL] [Abstract][Full Text] [Related]
3. c-erbB2 amplification and overexpression in human tumors. Lofts FJ; Gullick WJ Cancer Treat Res; 1992; 61():161-79. PubMed ID: 1360230 [TBL] [Abstract][Full Text] [Related]
4. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663 [TBL] [Abstract][Full Text] [Related]
5. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136 [TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene. Singleton TP; Strickler JG Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Lacroix H; Iglehart JD; Skinner MA; Kraus MH Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033 [TBL] [Abstract][Full Text] [Related]
9. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of the c-erbB-2 protein in human breast tumor cell lines. Hynes NE; Gerber HA; Saurer S; Groner B J Cell Biochem; 1989 Feb; 39(2):167-73. PubMed ID: 2565909 [TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061 [TBL] [Abstract][Full Text] [Related]
12. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Henry JL; Coggin DL; King CR Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095 [TBL] [Abstract][Full Text] [Related]
15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689 [TBL] [Abstract][Full Text] [Related]
16. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966 [TBL] [Abstract][Full Text] [Related]
17. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. Ooi A; Kobayashi M; Mai M; Nakanishi I Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947 [TBL] [Abstract][Full Text] [Related]
18. The erbB-3 gene in human pancreatic cancer. Lemoine NR; Lobresco M; Leung H; Barton C; Hughes CM; Prigent SA; Gullick WJ; Klöppel G J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525 [TBL] [Abstract][Full Text] [Related]
19. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation. George E; Niehans GA; Swanson PE; Strickler JG; Singleton TP Arch Pathol Lab Med; 1992 Oct; 116(10):1033-5. PubMed ID: 1358045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]